Thursday, June 2, 2022

Officially a Lobular Breast Cancer Advocate; Sikora Lab @ CU

 



I think I can now officially call myself a lobular breast cancer advocate. 


With a generous micro-grant from BCCRF, we hosted a #lobularbreastcancer event at CU Anschutz yesterday, featuring a clinical oncologist and a basic science researcher focused on ILC. Some shocking stats here, including that ILC dedicated research accounts for 0.5% of all breast cancer research published each year, despite representing 10-15% of cases. We can do better. Thanks to researchers like Matt Sikora PhD, we will. You can check out his work at www.Sikoralab.com 

Thank you to BCCRF, #cucancercenter#lobularbreastcanceralliance and to all those who came in person to attend. 

YouTube link: https://youtu.be/ay8DTb_4h_k

#breastcanceradvocacy #ihavelobularbreastcancer#breastcancerresearch #invasivelobularcarcinoma#breastcancereducation

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Aromatase Inhibitors, the "Hormone Blocker": 3 years on....

In my patient support groups and online social breast cancer circles, I read many comments a day asking about whom has chosen to take these,...